|
D68.318 |
Other hemorrhagic disorder due to intrinsic circulating anticoagulants, antibodies, or inhibitors |
| Billable Code | is a billable ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. |
| GEMS |
| ICD-10-CM D68.318 converts approximately to:ICD-9-CM |
| 2015 ICD-9-CM 286.59 Other hemorrhagic disorder due to intrinsic circulating anticoagulants, antibodies, or inhibitors |
| ICD-10-CM D68.318is grouped within Diagnostic Related Group(s) (MS-DRG v30.0) |
| 813 COAGULATION DISORDERS
|
| Alternate Description |
| Antithromboplastinemia |
| Antithromboplastinogenemia |
| Hemorrhagic disorder due to intrinsic increase in antithrombin |
| Hemorrhagic disorder due to intrinsic increase in anti-VIIIa |
| Hemorrhagic disorder due to intrinsic increase in anti-IXa |
| Hemorrhagic disorder due to intrinsic increase in anti-XIa |
| ICD-10-CM Index Entry |
| ICD-10-CM Index entries containing back-references to ICD-10-CM '.D68.318.' |
| Anticoagulant, circulating (intrinsic) |
| Antithromboplastinemia |
| Antithromboplastinogenemia |
| Circulating anticoagulants |
| Disorder (of); hemorrhagic NEC; due to; intrinsic; circulating anticoagulants |
| Disorder (of); hemorrhagic NEC; due to; intrinsic; increase in; antithrombin |
| Disorder (of); hemorrhagic NEC; due to; intrinsic; increase in; anti-VIIIa |
| Disorder (of); hemorrhagic NEC; due to; intrinsic; increase in; anti-IXa |
| Disorder (of); hemorrhagic NEC; due to; intrinsic; increase in; anti-XIa |
